Pharma R&D Today
Ideas and Insight supporting all stages of Drug Discovery & Development
AI Disease Modeling Supports Precision Medicine for Cancer
Posted on June 1st, 2021 by Matthew Morton in Pharma R&D
Precision medicine has offered a lot of hope for the treatment of cancer, as it makes it possible to tackle the multi-faceted disease with a more personalized, patient-specific approach. Meanwhile, researchers are also becoming increasingly interested in applications for artificial intelligence in the development of drugs and therapies. Could AI and precision medicine work together in the fight against cancer?
(more…)3D Printing Makes Medical Devices More Personal
Posted on December 10th, 2020 by Xuanyan Xu in Pharma R&D
Personalized medicine is a major trend in pharmaceutical R&D—and it’s transforming the way we think of therapeutics. Unlocking the secrets of the genome has made it possible to create treatments for disease that are more suited to the individual. But personalized medicine isn’t a concept that only applies to drug therapies. It is also highly relevant in the area of medical devices.
(more…)Bio-IT World Conference 2020 presentation: A Network Polypharmacology Approach to Diffuse Intrinsic Pontine Glioma
Posted on March 5th, 2020 by Xuanyan Xu in Pharma R&D
The Bio-IT World Conference & Expo, taking place in Boston from April 21-23, is an annual event that brings together thousands of great minds to highlight technologies and analytic approaches to solving problems, accelerating science and driving the future of precision medicine.
(more…)Dr. Anton Yuryev discusses pathways and precision medicine at PMWC
Posted on January 16th, 2020 by Xuanyan Xu in Pharma R&D
Why is pathway and molecular signaling critical for precision medicine? Dr. Anton Yuryev, Consulting Director of Professional Services at Elsevier, will be addressing that question and more in a presentation at the Precision Medicine World Conference in Silicon Valley this month.
(more…)
